Related Experiment Video
Updated: Feb 21, 2026

Surgical Placement of Catheters for Long-term Cardiovascular Exercise Testing in Swine
Published on: February 9, 2016
Physical Exercise Can Spur Beneficial Neoangiogenesis and Microvasculature Remodeling Within the Heart - Our
1Institute of Histology and Embryology, Faculty of Medicine, Comenius University in Bratislava, Bratislava, Slovak Republic. michal.miko@fmed.uniba.sk.
Abstract:
Economic and social burden of cardiovascular diseases remains enormous and even still rising. There is not enough mass evidence in scientific journals that could describe the course of the process of neoangiogenesis in relatively "healthy" heart after regular endurance exercise. Even though, in this review, we are showing preliminary evidence that this can be one of really cheap and effective preventive means. We are elucidating some of the cellular signaling pathways how exercise could affect neoangiogenesis and ameliorate performance of the heart. Key roles in this process are mechanical forces (mainly increased velocity of blood flow and shear stress) and subsequent rise of angiogenic biological factors (mainly VEGFA).
Related Concept Videos
Exercise and Cardiovascular Response
Light to moderate physical activity initiates a series of interconnected responses in the body. The heart rate modestly increases in anticipation of the workout, followed by widespread vasodilation as oxygen consumption by skeletal muscles increases. This results in decreased peripheral resistance, increased capillary blood flow, and accelerated...
Exercise and Cardiac Output
Sustained exercise increases the muscles' oxygen demand, which can be...
Pathophysiology of Cardiac Performance
Exercise and Muscle Performance
Endurance exercises
Endurance exercises involve running, swimming, or cycling, which require repetitive movements with low force output. When a person engages in endurance exercise, a few noticeable changes occur in their skeletal muscles. For instance, the number of capillaries...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
Heart Failure II: Pathophysiology

